ADO (ASX) Any positives?

Originally posted by jandb85: ↑

Trouble is it did feel right from public info given by the company.
When only a few weeks ago in late January we had the (hopefully soon to be former) CEO stand at a broadcast Qld government press conference with the health minister, deputy premier, chief health officer and clearly say not once but twice they had been manufacturing tests in Spain to supply European markets and could immediately supply millions of tests to assist Qld needs if approved, then double down again on next question and say they could of supplied millions of tests as far back as September 2021 when they first applied to TGA…

I watched it again today as that press conference was the sole reason I didn’t sell in late January when market cap was looking very top heavy. I wanted to be sure I wasn’t going crazy…nope still sane despite yesterdays blunt hit to the head from DT and being an anteo holder.

When you are told by CEO that TGA approval is imminent and CEO claiming company can supply millions immediately….…what other possible outcome is expected.
I base my investment decisions on facts provided by the company publicly.

I don’t base them on others opinions on a forum although I value others opinions and research, they don’t influence my decision to buy or sell, it is always on direct company info as that is supposed to be fact not fiction.

We all asked for honesty and to hear the real truth of the matter for the first time yesterday that there is no way possible millions of tests could of been supplied in September let alone in January they couldn’t even make enough to run a trial in Italy, or fill the empty prop boxes at HQ.

For this reason the CEO position is now totally untenable if he remains in position any longer then the close of business Monday it will be a complete farce. If he needs to stay due to contract place him as an MD ….. of the cookie jar or tea room.

There is no way this will turn around until current CEO is gone and Chairman can follow they are both ultimately responsible for current position of the business.

As a CEO and Chair you are ultimately responsible for all operational, cultural, financial and strategy decisions of the business.

The science teams have some amazing researchers the new board of advisors is promising, new hires for commercialisation of POC in Ian & Pierre are experienced operators and will do wonders for the business going forward, unfortunate the CEO and Chair were too slow to engage people like them earlier despite many shareholder voicing the need.

Derek and Jack have taken the business from a micro cap to a mid cap then now nearly back again.

It’s time to let someone new drive the bus and take this to a sustainable cap whatever that may end up being.

Let’s hope they get some more experienced heads in for energy sector commercialisation to assist Manuel and his team to bring their amazing research to reality.

Good luck to all hopefully that is the end of the mass exodus volume looked to dry up in afternoon session and with near on 370m changing hand in the last two days I hope for everyone’s sake the selling on mass is over, and some stability is found in the market cap.

Expand

Very disappointing, agree Chair and CEO need to go and all other Directors should at least halve their fee’s .I thought finally they were getting their act together but all BS.

No.	Vol.	Price($)
8	2717347	2.0¢

No.

Vol.

Price($)

2717347

2.0¢

Price($)	Vol.	No.
2.1¢	723484	6

Price($)

Vol.

No.

2.1¢

723484

No.	Vol.	Price($)
8	2717347	0.020
9	3029136	0.019
8	1708888	0.018
8	1211559	0.017
5	963250	0.016

No.

Vol.

Price($)

2717347

0.020

3029136

0.019

1708888

0.018

1211559

0.017

963250

0.016

Price($)	Vol.	No.
0.021	723484	6
0.022	442896	6
0.023	979953	9
0.024	1279435	5
0.025	2195344	5

Price($)

Vol.

No.

0.021

723484

0.022

442896

0.023

979953

0.024

1279435

0.025

2195344

(20min delay)
Last 2.0¢		Change 0.000(0.00%)		Mkt cap ! $49.36M

Open	High	Low	Value	Volume
2.0¢	2.1¢	2.0¢	$33.18K	1.658M

Very disappointing, agree Chair and CEO need to go and all other...

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Very disappointing, agree Chair and CEO need to go and all other...

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News